Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer

NCT01048320 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Imatinib

Sponsor

Royal Marsden NHS Foundation Trust